BioNTech SE (BNTX) Cash from Investing Activities (2018 - 2025)

BioNTech SE (BNTX) has 8 years of Cash from Investing Activities data on file, last reported at -$3.2 billion in Q4 2025.

• For the quarter ending Q4 2025, Cash from Investing Activities fell 589.38% year-over-year to -$3.2 billion; the trailing twelve-month figure through Dec 2025 stood at -$3.0 billion (down 32.79% YoY), and the FY2025 full-year result was -$2.8 billion, down 25.4% from the prior year.
• Cash from Investing Activities declined to -$3.2 billion in Q4 2025, from -$1.1 billion in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of $1.3 billion in Q1 2025 to a low of -$3.2 billion in Q4 2025.
• A 5-year average of -$588.0 million and a median of -$83.8 million in 2022 frame the typical range for Cash from Investing Activities.
• Across the five-year window, Cash from Investing Activities soared 96043426.27% in 2021 and plunged 2883.12% in 2023, its largest moves.
• Tracing BNTX's Cash from Investing Activities over 5 years: stood at $114.3 million in 2021, then jumped by 43.73% to $164.3 million in 2022, then sank by 1865.35% to -$2.9 billion in 2023, then soared by 122.36% to $648.3 million in 2024, then plunged by 589.38% to -$3.2 billion in 2025.
• Business Quant data shows BNTX's Cash from Investing Activities at -$3.2 billion in Q4 2025, -$1.1 billion in Q3 2025, and -$72.9 million in Q2 2025.